N.J. Admin. Code § 8:57-8.3

Current through Register Vol. 56, No. 11, June 3, 2024
Section 8:57-8.3 - Definitions

The following words and terms, as used in this subchapter, shall have the following meanings, unless the context clearly indicates otherwise:

"Advisory Committee on Immunization Practices" or "ACIP" means an advisory committee to the Centers for Disease Control and Prevention (CDC) that is made up of technical experts needed to advise the CDC on determining national immunization schedules and recommendations.

"Carrier" means a hospital service corporation (17:48-1 et seq.), a health service corporation (17:48E-1 et seq.), an insurer authorized to transact a health insurance business pursuant to Title 17B of the New Jersey Statutes, and a health insurance maintenance organization (26:2J-1 et seq.).

"Centers for Disease Control and Prevention" or "CDC" means the Federal agency which is the lead agency in the nation for disease prevention and control, located in Atlanta, Georgia.

"Deductible" means the amount of covered charges that are paid by the insured before his or her policy pays any benefits for such charges.

"DTP" means a combined vaccine which includes toxoids and antigens to prevent diphtheria, tetanus and pertussis diseases.

"DTaP" means a combined vaccine, which includes toxoids and antigens to prevent diphtheria, tetanus and a more purified antigenic component of the Bordetella pertussis (acellular pertussis) to prevent pertussis disease, and which may also reduce the likelihood of an adverse vaccine reaction.

"Health benefits plan" means any policy or contract delivered, issued for delivery or renewed in this State by a carrier that covers hospital or medical services or provides benefits for hospital or medical expenses.

"Hepatitis A" means a vaccine containing antigens to protect against hepatitis A disease.

"Hepatitis B immune globulin" or "HBIG" means hepatitis B immune globulin which is a short acting biological substance given only to individuals known to have been recently exposed to hepatitis B disease.

"Hepatitis B surface antigen" or "HBsAG" means a protein or carbohydrate substance which is present on the surface of the hepatitis B virus, and which stimulates the production of antibodies when introduced into the body.

"Hepatitis B virus vaccine" or "HBV" means a vaccine containing antigens to prevent hepatitis B virus disease.

"Immunization" means the immunizing agent itself, as well as the process and procedures associated with immunizing persons to prevent disease.

"Immunobiologics" means antigenic substances, such as vaccines or toxoids, or antibody-containing preparations, such as globulins and antitoxins, from human or animal donors. These products are used for active or passive immunization. The following are examples of immunobiologics: vaccine, toxoid, immune globulin (IG), intravenous immune globulin (IGIV), specific immune globulin, and antitoxin.

"Influenza vaccine" means vaccines that are produced annually to prevent disease from the most prevalent strains of influenza virus circulating in the world or country.

"Medical contraindication" means a condition in a recipient which is likely to result in a life-threatening problem if the vaccine were given.

"Morbidity and Mortality Weekly Report" or "MMWR"means a weekly publication issued by the United States Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, Atlanta, Georgia 30333.

"NJ FamilyCare" means a program of the Department of Human Services that provides health insurance for financially eligible children and families.

"Outbreak" means more than the normally expected number of cases of a disease occurring in a circumscribed location over a specified time period, normally days or weeks.

"Pneumococcal vaccine" means a vaccine, which contains antigens to prevent the occurrence of pneumonia in certain healthy and high risk populations, and includes pneumococcal conjugate vaccine or the pneumococcal polysaccharide vaccine.

"Post-exposure prophylactic doses" means prescribed amounts of vaccines and/or other medications which are administered to an individual who was, or who has a strong likelihood of having been exposed to a preventable disease.

"Td" means a combination vaccine which includes toxoids to prevent diphtheria and tetanus diseases only. It is normally recommended for older children and adults.

"Tdap" means a combination vaccine, which contains tetanus and reduced diphtheria toxoids and acellular pertussis antigens used as a booster vaccination to protect against diphtheria, tetanus, and pertussis diseases.

"Vaccines" means those immunizing agents composed of antigenic substances such as a vaccine or toxoid, or an antibody-containing preparation such as globulin when used to actively or passively immunize a person to prevent disease.

N.J. Admin. Code § 8:57-8.3

Recodified from N.J.A.C. 8:57-8.2 and amended by R.2009 d.107, effective 4/6/2009.
See: 40 N.J.R. 1962(a), 41 N.J.R. 1419(a).
Deleted definition "Commissioner"; in definition "DTaP", inserted comma following "combined vaccine" and substituted "Bordetella" for "Bordetalla"; added definitions "Hepatitis A", "NJ FamilyCare" and "Tdap"; and in definition "Pneumococcal vaccine", inserted a comma preceding "which contains" and inserted "healthy and" and ", and includes pneumococcal conjugate vaccine or the pneumococcal polysaccharide vaccine". Former N.J.A.C. 8:57-8.3, Immunizations that must be covered, recodified to N.J.A.C. 8:57-8.4.